Showing results (1031-1040 of 1,241) with videos related to

Sort By:
Pageof 125
JACC. Heart Failure|February 11, 2019
Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF RegistryPoghni A Peri-Okonny, Xiaojuan Mi, Yevgeniy Khariton, et al.
Circulation. Heart Failure|May 18, 2021
Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and DesignRobert J Mentz, Andrew P Ambrosy, Justin A Ezekowitz, et al.
Journal of Cardiac Failure|July 21, 2023
Morbidity and Mortality Associated With Heart Failure in Acute Coronary Syndrome: A Pooled Analysis of 4 Clinical TrialsNathan P Goodwin, Robert M Clare, Josephine L Harrington, et al.
Circulation. Heart Failure|July 7, 2023
Background Medical Therapy and Clinical Outcomes From the VICTORIA TrialJustin A Ezekowitz, Ciaran J McMullan, Cynthia M Westerhout, et al.
The Annals of Thoracic Surgery|March 19, 2022
Palliation Plus Ventricular Assist Device Insertion in 15 Neonates and Infants With Functionally Univentricular CirculationMark S Bleiweis, Joseph Philip, Giles J Peek, et al.
Environmental Pollution (Barking, Essex : 1987)|July 6, 2019
Childhood chromium exposure and neuropsychological development in children living in two polluted areas in southern SpainRafael A Caparros-Gonzalez, M José Giménez-Asensio, Beatriz González-Alzaga, et al.
JACC. Advances|July 30, 2024
Interleukin-6 and Cardiovascular Events in Healthy Adults: MESAMuhammad Shahzeb Khan, Khawaja M Talha, Muhammad Haisum Maqsood, et al.
Health and Quality of Life Outcomes|June 14, 2021
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trialsTheresa M Coles, Adrian F Hernandez, Bryce B Reeve, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Scientific Opinion on the setting of health-based reference values for metabolites of the active substance terbuthylazine, Antonio F Hernandez-Jerez, Paulien Adriaanse, et al.
European Journal of Heart Failure|November 6, 2022
Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trialAlexander Peikert, Brian L Claggett, KyungMann Kim, et al.
Pageof 125